|
2023
|
Invention
|
Fused azines as dynamin-1-like protein inhibitors and uses thereof. Provided are compounds of the... |
|
|
Invention
|
Transcription factor eb activators and uses thereof. Provided are pharmaceutical compositions com... |
|
|
Invention
|
Aryl alkynamide derivatives. A compound which is useful as a STING inhibitor is provided. The pre... |
|
2022
|
Invention
|
Methods of use of ppar agonist compounds and pharmaceutical compositions thereof. The present dis... |
|
|
Invention
|
Salt and crystal forms of an hmox1 inducer. Disclosed is the 1:1 phosphate salt of Compound (I) a... |
|
2021
|
Invention
|
Cd38 inhibitors. One embodiment of the invention is a compound represented by Formula I: or a pha... |
|
|
Invention
|
Salt and crystal forms of an hmox1 inducer. Disclosed is the 1: 1 phosphate salt of Compound (I) ... |
|
2020
|
Invention
|
N-cyclohexyl-5-(thiazol-5-yl)-1h-indole-7-carboxamide derivatives and related compounds as cd38 i... |
|
|
Invention
|
Hmox1 inducers. The present invention is related to compounds of structure (I) as heme oxygenase ... |
|
2019
|
Invention
|
Ppar agonists. Provided herein are compounds and compositions useful in increasing PPARδ activity... |
|
2018
|
Invention
|
Usp30 inhibitors. The application relates to phenyl- or naphthylsulfonamide derivatives of the st... |
|
|
Invention
|
Dynamin-1-like protein inhibitors. This application is directed to inhibitors of dynamin-l-like p... |
|
2017
|
Invention
|
Poly-adp ribose polymerase (parp) inhibitors. The present invention is related to a pharmaceutica... |
|
|
Invention
|
Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (acmsd) inhibit... |
|
|
Invention
|
Crystalline and salt forms of ppar agonist compounds. This disclosure relates to salt forms of co... |
|
|
Invention
|
Methods of treating acute kidney injury. The present invention is directed to methods of treating... |
|
|
Invention
|
Methods of treating acute kidney injury. The present invention also contemplates a method of trea... |
|
|
Invention
|
Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof. Provided herei... |
|
2016
|
Invention
|
Nicotinamide riboside and nicotinamide mononucleotide derivatives for use in the treatments of mi... |
|
|
Invention
|
Ppar-alpha agonists for treating mitochondrial diseases. Provided herein are methods for increasi... |
|
2015
|
Invention
|
Ppar-delta agonists for use for treating mitochondrial, vascular, muscular, and demyelinating dis... |
|
|
P/S
|
scientific research, pharmaceutical research and product development for others in the field of d... |
|
2014
|
Invention
|
Ppar agonists. Provided herein are compounds and compositions useful in increasing PPARd activity... |
